These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8189539)

  • 1. Glycosylphosphatidylinositol-anchored CD4 supports human immunodeficiency virus type 1 replication, but not cytopathic effect, in T-cell transfectants.
    Marshall WL; Mittler ES; Avery P; Lawrence JP; Finberg RW
    J Virol; 1994 Jun; 68(6):4039-42. PubMed ID: 8189539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants.
    Marshall WL; Diamond DC; Kowalski MM; Finberg RW
    J Virol; 1992 Sep; 66(9):5492-9. PubMed ID: 1501285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein.
    Kowalski M; Bergeron L; Dorfman T; Haseltine W; Sodroski J
    J Virol; 1991 Jan; 65(1):281-91. PubMed ID: 1702159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
    Miller MD; Warmerdam MT; Gaston I; Greene WC; Feinberg MB
    J Exp Med; 1994 Jan; 179(1):101-13. PubMed ID: 8270859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI.
    Chun TW; Chadwick K; Margolick J; Siliciano RF
    J Virol; 1997 Jun; 71(6):4436-44. PubMed ID: 9151834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26.
    Lazaro I; Naniche D; Signoret N; Bernard AM; Marguet D; Klatzmann D; Dragic T; Alizon M; Sattentau Q
    J Virol; 1994 Oct; 68(10):6535-46. PubMed ID: 7916060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus infection and syncytium formation in HeLa cells expressing glycophospholipid-anchored CD4.
    Kost TA; Kessler JA; Patel IR; Gray JG; Overton LK; Carter SG
    J Virol; 1991 Jun; 65(6):3276-83. PubMed ID: 1709701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intercellular transfer of a glycosylphosphatidylinositol (GPI)-linked protein: release and uptake of CD4-GPI from recombinant adeno-associated virus-transduced HeLa cells.
    Anderson SM; Yu G; Giattina M; Miller JL
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5894-8. PubMed ID: 8650189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization of adult primary human immunodeficiency virus type 1: demonstration of distinctive single-cell killing phenotypes in spite of similar levels of viral replication.
    Pal A; Greenough TC; Sullivan JL; Somasundaran M
    J Infect Dis; 1997 Oct; 176(4):933-40. PubMed ID: 9333151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein.
    Weiss CD; White JM
    J Virol; 1993 Dec; 67(12):7060-6. PubMed ID: 8230430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4.
    Diamond DC; Finberg R; Chaudhuri S; Sleckman BP; Burakoff SJ
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5001-5. PubMed ID: 2142306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells.
    LaBonte JA; Patel T; Hofmann W; Sodroski J
    J Virol; 2000 Nov; 74(22):10690-8. PubMed ID: 11044113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion from without directed by human immunodeficiency virus particles.
    Clavel F; Charneau P
    J Virol; 1994 Feb; 68(2):1179-85. PubMed ID: 8289347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
    Popik W; Alce TM; Au WC
    J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the human CD38 glycoprotein on the early stages of the HIV-1 replication cycle.
    Savarino A; Bottarel F; Calosso L; Feito MJ; Bensi T; Bragardo M; Rojo JM; Pugliese A; Abbate I; Capobianchi MR; Dianzani F; Malavasi F; Dianzani U
    FASEB J; 1999 Dec; 13(15):2265-76. PubMed ID: 10593874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
    Mulligan MJ; Ritter GD; Chaikin MA; Yamshchikov GV; Kumar P; Hahn BH; Sweet RW; Compans RW
    Virology; 1992 Mar; 187(1):233-41. PubMed ID: 1736526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
    Grimaila RJ; Fuller BA; Rennert PD; Nelson MB; Hammarskjöld ML; Potts B; Murray M; Putney SD; Gray G
    J Virol; 1992 Apr; 66(4):1875-83. PubMed ID: 1548744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1.
    Cohen DI; Tani Y; Tian H; Boone E; Samelson LE; Lane HC
    Science; 1992 Apr; 256(5056):542-5. PubMed ID: 1570514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120.
    Sakihama T; Smolyar A; Reinherz EL
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6444-8. PubMed ID: 7604010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.